Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia
AS Elbnnani, M Elbasir, S Altabal… - Libyan Journal of …, 2024 - Taylor & Francis
The diagnosis of acute lymphoblastic leukemia (ALL), which is the most common type of
cancer in children, has become more accurate with the use of flow cytometry. Here, this …
cancer in children, has become more accurate with the use of flow cytometry. Here, this …
Supervivencia e inmunofenotipos en pacientes con leucemias agudas diagnosticados por citometría de flujo en un hospital nivel III de Chiclayo Perú 2015-2019
JD Juárez Ynoñan - 2024 - repositorio.unprg.edu.pe
La inmunofenotipificación proporciona información importante para el diagnóstico,
clasificación y seguimiento de neoplasias hematológicas al permitir la identificación …
clasificación y seguimiento de neoplasias hematológicas al permitir la identificación …
[PDF][PDF] Expression of aberrant markers in acute leukemia at south Egypt cancer institute: A retrospective study
MA Mohamed, EA Shafik, AO Ahmed… - SECI Oncol, 2021 - secioj.journals.ekb.eg
Background: Aberrant phenotypes in acute leukemia (AL) have variable frequency and their
prognostic relevance is controversial and dissimilar results have been reported by different …
prognostic relevance is controversial and dissimilar results have been reported by different …
[PDF][PDF] BCR-ABL 融合基因与免疫表型在急性B 淋巴细胞白血病中的相关性研究
常子维, 谈捷, 李秋红, 唐海龙… - Progress in Modern …, 2023 - biomed.cnjournals.com
摘要目的: 通过回顾性分析急性淋巴细胞白血病的免疫分型结果及融合基因表达情况, 研究BCR-
ABL 融合基因与免疫表型的相关性. 方法: 用运SPSS23. 0 软件及流式分析软件KALUZA …
ABL 融合基因与免疫表型的相关性. 方法: 用运SPSS23. 0 软件及流式分析软件KALUZA …
[PDF][PDF] Frequency of CD34 expression in acute lymphoblastic leukaemia and its correlation with clinicopathological characteristics: A single centre experience from …
Background: This study was carried out to determine the frequency of CD34 positivity in
acute lymphoblastic leukaemia (B-ALL) in our population and to report its association with …
acute lymphoblastic leukaemia (B-ALL) in our population and to report its association with …
Terapias biológicas no tratamento da leucemia linfoblástica aguda: eficácia e segurança
MN Pires - 2023 - repositorio.ul.pt
A leucemia linfoblástica aguda é uma neoplasia hematológica caracterizada pela
proliferação de células linfoides imaturas na medula óssea, sangue periférico e outros …
proliferação de células linfoides imaturas na medula óssea, sangue periférico e outros …
Evaluation of the Correlation of Immunohistochemical Findings with Flow Cytometric Findings in Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia Patients
Background and objectives: The development of new therapeutic options to treat leukemia
(therapies targeting chimeric antigen receptor [CAR] T cells) down-regulates markers …
(therapies targeting chimeric antigen receptor [CAR] T cells) down-regulates markers …
Detection of Aberrant Phenotypes in Acute Leukemia Patients in Relation to Some Hematological Parameters
HAH Moustafa, KAHM Mahfouz… - … Journal of Medical …, 2023 - journals.ekb.eg
Background: Patients with acute leukemia [AL] may express aberrant antigens that are
normally restricted to a different lineage. We evaluated the frequency of aberrancy in AL …
normally restricted to a different lineage. We evaluated the frequency of aberrancy in AL …
Immunophenotypic Profile Of Acute Lymphoblastic Leukemia Patients In The Iraqi Kurdish Population And Their Association With The Response To Chemotherapy …
MQ Mustafa, GQ Othman - Journal of Pharmaceutical Negative …, 2022 - pnrjournal.com
The diagnosis and immunophenotyping of acute lymphoblastic leukemia (ALL) are best
accomplished through the use of flow cytometry. This study aimed to evaluate the …
accomplished through the use of flow cytometry. This study aimed to evaluate the …
Immunophenotyping and Minimal Residual Disease in Palestinian children under 15 with Acute Lymphoblastic Leukemia: A Retrospective Study from Beit Jala …
NSA Nazzal - 2022 - repository.aaup.edu
Leukemia is an abnormality of many blood cells because of a defect in bone marrow. It
influences mostly elderly people aged 55 years and above but it is also a known cancer in …
influences mostly elderly people aged 55 years and above but it is also a known cancer in …